D
NurExone Biologic Inc. NRXBF
$0.50 $0.011.31% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Total Cash And Short-Term Investments 108.84% -16.00% -72.26% 5.79% -26.73%
Total Receivables -37.78% 6.30% -50.97% -27.65% -8.21%
Inventory 0.00% 0.00% -- -- --
Prepaid Expenses -- -- -- -- --
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets 0.00% 0.00% 0.00% 0.00% 28.13%
Total Current Assets 43.18% -16.52% -42.12% 1.40% -24.29%

Total Current Assets 43.18% -16.52% -42.12% 1.40% -24.29%
Net Property, Plant & Equipment 17.40% -3.84% 2.02% 55.71% 9.25%
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets -- -- -- -- --
Total Assets 33.83% -12.33% -32.46% 9.78% -20.52%

Total Accounts Payable -- -- -- -- --
Total Accrued Expenses 75.94% -44.84% 97.09% -0.58% -25.11%
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -- -- -- -- --
Total Finance Division Other Current Liabilities 85.25% 542.11% -78.33% -29.49% 184.73%
Total Other Current Liabilities 85.25% 542.11% -78.33% -29.49% 184.73%
Total Current Liabilities 82.10% 38.94% -8.51% -20.33% 50.83%

Total Current Liabilities 82.10% 38.94% -8.51% -20.33% 50.83%
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases 193.55% 0.00% 0.00% 24.00% 4.17%
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -2.50% -4.38% 14.09% 50.68% 16.80%
Total Liabilities 61.65% 21.18% -0.87% -4.32% 40.31%

Common Stock & APIC 11.46% 15.86% -0.92% 5.68% 2.01%
Retained Earnings -8.88% -8.79% -8.81% -7.67% -8.85%
Treasury Stock & Other -16.54% -48.15% 20.12% 31.59% -2.93%
Total Common Equity 16.41% -25.27% -39.86% 13.71% -29.08%

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity 16.41% -25.27% -39.86% 13.71% -29.08%
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity 16.41% -25.27% -39.86% 13.71% -29.08%